Bullish
Profusa Adopts NVIDIA-Powered Technology to Build AI-Driven Insight Portal for Continuous Biomarker Monitoring
Company expects early 2026 rollout in EEA. physician portal combines Lumee™ oxygen monitoring with NVIDIA NeMo to deliver AI-driven clinical ...